Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No, but that’s hardly the point to my mind. I rode this from .018 to .07–and like a FOOL believed that they were ready to break out. Left probably $30K (of house money admittedly) on the table by holding long and strong. Now that it has dipped, I’ve loaded and am now cost-averaged at less than .01/share—just in time for a “thank you” gut punch for my patience...
Take 5.1 shares and divide by 75=68,000 shares. Multiply .0006 * 75= .045
68,000 * .045 =$3,060
By contrast, 5.1M shares times .045 (about HALF of where we were in early 2018)=$229,500
Notice any difference???
I’m furious about the RS—and would expect the same from anyone else who’s waited patiently here for 2+ years. Some kick in the teeth...
And yet MMs are lined up to buy twice as many shares on the bid as they have for sale on the ask. Are they anticipating something?
At worst it’s staying neutral—my point is that there is ample buying of the available shares (otherwise the PPS would continue tanking toward .0001).
Then why is it going UP?
MASSIVE demand from somewhere: bid quantity is almost 10X ask quantity.
Who says that? It’s not an absolute requirement. You can surely have selling without buying—but NEVER buying without selling
No intent to go away
The question, however, is will our steadfast patience (many of us for 2+ years) and commitment to this as a business INVESTMENT be “rewarded” by a reverse split that neuter our appreciation power by reducing our share count 25-75x.
They are in NO position to play games: come correct for ONCE!
PPS of the other major players? Asking for a friend
Not quite sure why/ how you figure we’ll never go to .15+ again. After the RS the OS, even if it swells to 6B before the RS, would be a paltry 80M is the factor is 1:75.
Then they will have neither in the end.
Of course, everyone loses some money in the OTC. I’m referring to unrelenting persistence in follow through and proving a point (as anyone her for the last two years will have recognized). This dog doesn’t let go...
If this is proven to be a scam, ANYONE associated won’t be able to save their reputations—at any price.
This game is hardly done—and I don’t lose
Whatever. I’ll trust the governments and professional financiers who have ponied up MAJOR bank to fund BLSP into the foreseeable future. Peace.
One naturally wonders WHY they had principals talking about it on social media (many have screenshots and the rest can be subpoenaed, if need be), if they weren’t ready to pursue commercialization AGGRESSIVELY. If you don’t have the capacity to train docs quickly and aggressively, you don’t talk about what you’ve accomplished. That damage is DONE: they have ONE chance to salvage themselves in all this...
If true, there will be NOWHERE on this GLOBE that ANY of them will be able to go and NOT be reached by the justice that would be coming their way—in SO many ways. I’m reserving the right to consider them more legitimately strategic and/or administratively ham-fisted at this point in time...
To sound in here: Don dropped me on “the links,” apparently because I dared to ask REAL questions—again, BAD form for a group that’s allegedly interested in transparency and promoting goodwill with shareholders.
I’m doing my best to maintain belief in their enterprise and in them as leaders (based on their prior track record and the potential of the stem cell industry over the next 5 years), but THEY are doing THEIR best to make themselves seem directionally aimless, slimy, and unscrupulous.
2 clear possibilities. Given timing of Tim’s interview that aired yesterday, either (1) he’s the new poster child for corporate malfeasance given his failure to mention the apparently imminent RS (both by formal PR and in the interview) OR (2) this is purposeful: they will let this tank, use the $ from investors to buyback at almost nothing, announce POSITIVE EPS—and then convince investors that RS is not needed.
If the RS occurred today, at .0006, and at a factor of 1:75 (which seems increasingly likely), the resulting price would be a whopping .045–roughly a little more than HALF of where we were a year and a half ago. So what’s the positive in that scenario (thanks for your patience—I’m slow and dumb)?
OTCX is back—must mean EVEN MORE dumping
1. “Simple procedure”—so simple that it takes incalculable time to train the physicians—one at a time a là the 1970s apparently—with roughly 50 total procedures having apparently been performed in an entire quarter ended 6/30/2019.
2. Where was this interview activity at ANY point in the last two years?
3. Funny thing, no mention of the impending RS (and this interview coming right on the heels of that notice of intent)?
What part of “they are about to ANNIHILATE our shares” do you not understand? Are you OK with that? And all so they can “reset” the stock to somewhere between .05 and .10–which is where it ALREADY WAS a year and a half ago? Moreover, they continue with the glacial progress AND the virtual silence in terms of MEATY NUMBERS that would allow for adequate analysis and evaluation of their business model and progress.
How many more billions will they dilute before the RS? What reason do they have NOT to at this point? Trust, once violated, can never be restored...
Put down the pipe: down almost 30%...
Taking the “commercialization” of CaverStem as an indicator (by my reckoning they performed a whopping 50 or so procedures during the ENTIRE QUARTER that ended 6/30/19–estimated by reconciling Revs with COGS, and predicated on the fairly solid notion that the company nets around $1,600 per procedure), “Group Glacial” will be crawling along with StemSpine at around that same pace a year from now when those notes come due. UNBELIEVABLE!
Gapping DOWN at open—who could have known?
One POSSIBLE silver lining: if they are able to release enough good news to present a compelling argument to the investors and convince them that the RS is not needed after all, then that would be a MAJOR achievement. As things stand now, I remain skeptical at best.
This better be trading in the multiple dollars SOON—or I will join the drumbeat and chorus of those calling this a scam and a joke (and, like Bill Bixby used to say, “you won’t like me when I’m angry”).
Those with share counts in the millions will be utterly NEUTERED by this. Thanks a million (sarcasm intended).
Then why not let this run organically? This whole sh*tshow is the result of them not commercializing aggressively enough by training doctors more rapidly so as to proliferate more quickly. Oh, and the BUST on Russia didn’t help either.
In principle, makes a certain amount of sense. But the FACTOR is the issue—reducing our potency by 25 to 75?!
But then why did they just INCREASE the AS to 6B? Either they knew about the planned RS when they did that—and therefore plan to dilute to the moon AGAIN after the RS—or they were clueless and didn’t plan the two actions in conjunction. Either way, it reeks!!!
So how does a RS that fractionalizes shares by somewhere between 1:25 and 1:75 increase shareholder value? Any rise in PPS (assuming it happens AND is sustained) is GREATLY overmatched by the colossal reduction in shares.